Dexamethasone and methylprednisolone do not inhibit neuritic outgrowth while inhibiting outgrowth of fibroblasts from spiral ganglion explants

Acta Oto-Laryngologica

Volumn 128, Issue 2, 2008, Pages 122-127

  Furze, Alexis ^a,b   Kralick, Deanna ^a,c   Vakharia, Anand ^a,c   Jaben, Korey ^a   Graves, Reid ^a   Adil, Eelam ^a   Eshraghi, Adrien A ^a   Balkany, Thomas J ^a   Van De Water, Thomas R ^a  

^a UNIVERSITY OF MIAMI EAR INSTITUTE   (United States)

^b UNIVERSITY OF TEXAS AT DALLAS   (United States)

^c UNIVERSITY OF MIAMI   (United States)

Author keywords

Auditory neurons; Cochlear implantation; Dexamethasone; Fibroblast outgrowth; hrBDNF; Methylprednisolone; Neurite outgrowth; Spiral ganglion; Triamcinolone acetonide

Indexed keywords

DEXAMETHASONE; METHYLPREDNISOLONE; RECOMBINANT BRAIN DERIVED NEUROTROPHIC FACTOR; TRIAMCINOLONE ACETONIDE;

ACOUSTIC NERVE FIBER; ANIMAL TISSUE; ARTICLE; CAMERA; COCHLEA PROSTHESIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; DATA ANALYSIS SOFTWARE; DRUG EFFECT; EXPLANT; FIBROBLAST; IMAGE ANALYSIS; MICROSCOPE; NERVE FIBER GROWTH; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; SPIRAL GANGLION; SPRAGUE DAWLEY RAT; TISSUE CULTURE;

ANIMALS; ANIMALS, NEWBORN; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELL DIVISION; CELLS, CULTURED; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBROBLASTS; IMMUNOENZYME TECHNIQUES; METHYLPREDNISOLONE; NEURITES; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; SPIRAL GANGLION; TRIAMCINOLONE ACETONIDE;

EID: 38349060074     PISSN: 00016489     EISSN: 16512553     Source Type: Journal    
DOI: 10.1080/00016480701390128     Document Type: Article

References (25)

1. Clark GM, Shute SA, Shepherd RK, Carter TD. Cochlear implantation: osteoneogenesis, electrode-tissue impedance, and residual hearing. Ann Otol Rhinol Laryngol 1995;166(Suppl):40-2.
2. Tykocinski M, Cohen LT, Pyman BC, Roland T Jr, Treaba C, Palamara J, et al. Comparison of electrode position in the human cochlea using various perimodular electrode arrays. Am J Otol 2000;21:205-11.
3. Brors D, Aletsee C, Schwager K, Mlynski R, Hansen S, Schafers M, et al. Interaction of spiral ganglion neuron processes with alloplastic materials in vitro. Hear Res 2002;167:110-21.
4. Hartnick CJ, Staecker H, Malgrange B, Lefebvre PP, Liu W, Moonen G, et al. Neurotrophic effects of BDNF and CNTF, alone and in combination, on postnatal day 5 rat acoustic ganglion neurons. J Neurobiol 1996;30:246-54.
5. Staecker H, Kopke RD, Malgrange B, Lefebvre PP, Van De Water TR. NT-3 and/or BDNF therapy prevents loss of auditory neurons following loss of hair cells. Neuroreport 1996;7:889-94.
6. Henson A, Slattery WH III, Luxford WM, Mills DM. Cochlear implant performance after reimplantation. Am J Otol 1999;20:56-64.
7. Clark GM, Shepherd RK, Franz BK, Dowell RC, Tong YC, Blamey PJ, et al. The histopathology of the human temporal bone and auditory central nervous system following cochlear implantation in a patient. Correlation with psychophysics and speech perception results. Acta Otolaryngol Suppl 1988;448:1-65.
8. Leake-Jones PA, Rebscher SJ. Cochlear pathology with chronically implanted scala tympani electrodes. Ann N Y Acad Sci 1983;405:203-23.
9. Namba M, Asano K, Kanai K, Kyo Y, Watanabe S, Hisamitsu T, et al. Suppression of matrix metalloproteinase production from nasal fibroblasts by fluticasone propionate in vitro. Acta Otolaryngol (Stockh) 2004;124:964-9.
10. Vento G, Matassa PG, Ameglio F, Capoluongo E, Tortorolo L, Romagnoli C, et al. Effects of early dexamethasone therapy on pulmonary fibrogenic mediators and respiratory mechanics in preterm infants. European Cytokine Network 2002;13:207-14.
11. Tahera Y, Meltser I, Johansson P, Canlon B. Restraint stress modulates glucocorticoid receptors and nuclear factor kappa B in the cochlea. Neuroreport 2006;17:879-82.
12. Tahera Y, Meltser I, Johansson P, Salman H, Canlon B. Sound conditioning protects hearing by activating the hypothalamic-pituitary-adrenal axis. Neurobiol Dis 2007;25:189-97.
13. Himeno C, Komeda M, Izumikawa M, Takemura K, Yagi M, Weiping Y, et al. Intra-cochlea administration of dexamethasone attenuates aminoglycoside ototoxicity in the guinea pig. Hear Res 2002;167:61-70.
14. Taremura K, Komeda M, Yagi M, Himeno C, Izumikawa M, Doi T, et al. Direct inner ear infusion of dexamethasone attenuates noise-induced trauma in the guinea pig. Hear Res 2004;196:56-68.
15. Tabuchi K, Oikawa K, Murasshita H, Hoshino T, Tsuji S, Hara A. Protective effect of glucocorticoids on ischemia-reperfusion injury to outer hair cells. Laryngoscope 2006;116:627-9.
16. Eshraghi AA, Adil E, He J, Graves R, Balkany TJ, Van De Water TR. Local dexamethasone therapy conserves hearing in an animal model of electrode insertion trauma. Otol Neurotol 2007 (in press).
17. Parnes LS, Sun A-H, Freeman DJ. Corticosteroid pharmacokinetics in the inner ear fluids: an animal study followed by clinical application. Laryngoscope 1999;109(Suppl 91):1-17.
18. Terunuma T, Kawauchi S, Kajihara M, Takahashi S, Hara A. Effect of acoustic stress on glucocorticoid receptor mRNA in the cochlea of the guinea pig. Brain Res Mol Brain Res 2003;120:65-72.
19. Mori T, Fujimura K, Yoshida M, Suzuki H. Effects of glucocorticoid receptor antagonist on CAPs threshold shift due to short-term sound exposure in guinea pigs. Auris Nasus Larynx 2004;31:3959.
20. De Ceulaer G, Johnson S, Yuperman M, Daemers K, Officiers FE, O'Donoghue GM, et al. Long-term evaluation of intracochlear steroid deposition on electrode impedance in cochlear implant patients. Otol Neurotol 2003;24:769-74.
21. Oddera S, Cagnoni F, Mangraviti S, Giron-Michel J, Popova O, Canonic GW. Effect of triamcinolone acetonide on adult human lung fibroblasts: decrease in proliferation, surface molecule expression and mediator release. Int Arch Allergy Immunol 2002;129:152-9.
22. Zou J, Curtis LM, Yao X, ten Cate WJ, Bagger-Sjöbäck D, Hultcrantz M, et al. Glucorticoid receptor expression in the postnatal rat cochlea. Hear Res 1995;87:220-7.
23. Hasson AC, Sommer WH, Metsis M, Stromberg I, Agnati LF, Fuxe K. Corticosterone actions on the hippocampus brain-derived neurotrophic factor expression are mediated by exon IV promoter. J Neuroendocrinology 2006;18:104-14.
24. Nicholas A, Munhoz CD, Ferguson D, Campbell L, Sapolsky R. Enhancing cognition after stress with gene therapy. J Neurosci 2006;26:11637-43.
25. Leonelli E, Ballabio M, Consoli A, Roglio I, Magnaghi V, Melcangi RC. Neuroactive steroids: a therapeutic approach to maintain peripheral nerve integrity during neurodegenerative events. J Mol Neurosci 2006;28:65-76.